NeuroBrave
PrivateLast Round
Grant
Jul 9, 2024
Total Funding Raised
$1.4M
Company Overview
NeuroBrave is a neurotechnology company that develops an AI-powered software platform, NeuroSpeed OS, which transforms sensory data from wearables and biosensors into real-time cognitive and emotional insights.
Sector
AI, Data & Cloud Infrastructure
Verticals
Health IoT, Smart Manufacturing, Gaming, Sensors, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroBrave Comparables
Compare NeuroBrave with similar companies based on industry and business-model similarity.
NeuroBrave Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 9, 2024 | ||||
| Seed | Dec 19, 2022 | ||||
| Seed | Aug 2, 2021 |
NeuroBrave Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Labs/02 | Seed |
| VentureIsrael | Seed |
| Samurai Incubate | Seed |
| Italian Angels for Growth | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 4, 2026
Grew 71% QoQ, from 24 to 41 employees.
- Jan 1, 2026
Grew 54% QoQ, from 24 to 37 employees.
NeuroBrave Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroBrave's valuation, stock price, and market status.